IP Library › Granted Patent US 11,485,764
Granted Patent B2
US 11,485,764 · App. 16/904,978 · Granted Nov 1, 2022

Production of recombinant lubricin

Inventors: Tannin A. Schmidt (Avon, CT); Gregory D. Jay (Norfolk, MA)
Assignee: Lubris LLC
C07K14/4725A61K9/008A61K9/0014A61K9/0019A61K9/0048A61K31/728A61K38/1709A61K47/36C12P21/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,485,764
App. No.
16/904,978
Granted
Nov 1, 2022
Kind
B2
Abstract

Disclosed are new recombinant isoforms of human-like lubricin or PRG4 glycoprotein having outstanding lubrication properties and a novel glycosylation pattern, and methods for their manufacture at high levels enabling commercial production.

Claims (18)

1. A method of manufacture of a recombinant lubricin glycoprotein comprising the steps of:

culturing, in a medium, Chinese hamster ovary (CHO) cells transfected with and which express the human PRG4 gene and post translationally glycosylate the expression product, wherein said culturing is for a time and under culture conditions sufficient to produce a lubricin glycoprotein comprising at least 30% by weight glycosidic residues and at a concentration in the medium of at least 0.4 g lubricin glycoprotein/liter, wherein at least 90% of said glycosidic residues are core 1 glycosidic residues; and

purifying the lubricin glycoprotein from said medium.

2. The method of claim 1 , wherein the CHO cells are CHO-M cells comprising a nucleic acid encoding the human PRG4 gene.

3. The method of claim 1 , wherein the CHO cells are transfected with a first vector comprising a nucleic acid encoding a chromatin element and a second vector comprising a nucleic acid encoding the human PRG4 gene.

4. The method of claim 3 , wherein the chromatin element is a boundary element, matrix attachment region, locus control region or a universal chromatin opening element.

5. The method of claim 4 , wherein the chromatin element is a matrix attachment region.

6. The method of claim 1 , wherein the culturing is for a time and under culture conditions sufficient to produce said lubricin glycoprotein at a concentration in the medium of at least 0.5 g/liter.

7. The method of claim 1 , wherein the culturing is for a time and under culture conditions sufficient to produce said lubricin glycoprotein at a concentration in the medium of at least 0.8 g/liter.

8. The method of claim 1 , wherein at least 95% by weight of glycosylation of the lubricin glycoprotein is core 1 glycosylation.

9. The method of claim 1 , wherein at least 99% by weight of glycosylation of the lubricin glycoprotein is core 1 glycosylation.

10. The method of claim 1 , wherein the glycosidic residues are enriched in sulfated saccharide side chains as compared with native human lubricin.

11. The method of claim 1 , wherein the lubricin glycoprotein comprises a monomeric lubricin species co-purified from said culture medium and in admixture with a multimeric lubricin species.

12. The method of claim 1 , wherein the lubricin glycoprotein comprises a dimeric lubricin species.

13. The method of claim 1 , wherein the lubricin glycoprotein has a molecular weight of at least 1200 kDa and comprises at least five disulfide-bonded or non-covalently associated individually glycosylated amino acid chains.

14. The method of claim 1 , wherein the culturing is in at least 10, 50, or 100 liters of medium.

15. The method of claim 1 , wherein the lubricin glycoprotein comprises at least 35% by weight glycosidic residues.

16. The method of claim 1 , wherein the recombinant lubricin glycoprotein comprises the amino acid sequence of SEQ ID NO:1.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2025
From: SCHMIDT, TANNIN; JAY, GREGORY D.
To: LUBRIS LLC
Reel/Frame 071249/0932 →
Continuity (4)
Continuation 16183497 · Nov 7, 2018
Continuation 15030825
Provisional Application 61849366 · Jan 25, 2013
Related Publication 20210130427A1 · May 6, 2021